Prompt

Are there any biologics CDMO services that focus on commercial biologics supply for recombinant proteins?

Pharmaceuticals / CDMO2 observationsLast seen Oct 5, 2026

Latest observation

Oct 5, 2026OpenAI APIWeb search: off

Yes. There are several biologics CDMOs that specifically support commercial supply of recombinant protein biologics rather than only early-stage development. These providers typically offer cell line development, upstream/downstream process development, GMP manufacturing, fill-finish, and lifecycle/commercial supply support.

Examples include:

  • Lonza – Large-scale commercial biologics manufacturing for recombinant proteins and other biologics.
  • Samsung Biologics – Commercial monoclonal antibody and recombinant protein manufacturing at large scale.
  • WuXi Biologics – End-to-end biologics services including commercial manufacturing for recombinant proteins.
  • Boehringer Ingelheim BioXcellence – Commercial biologics CDMO services for recombinant proteins, antibodies, and other proteins.
  • Thermo Fisher (Patheon / Gibco network) – Biologics development and manufacturing capabilities, including commercial support in some regions.
  • Catalent Biologics – Biologics development and manufacturing, with commercial supply capabilities for selected programs.
  • AGC Biologics – Commercial production of recombinant proteins and other biologics across mammalian and microbial platforms.
  • KBI Biopharma – Biologics development and GMP manufacturing, with commercial supply support depending on program and site.
  • FUJIFILM Diosynth Biotechnologies – Commercial manufacturing of recombinant proteins and other biologics.
  • Valneva/other niche CDMOs – Some smaller CDMOs also support commercial recombinant protein supply depending on platform and scale.

A few things to check when evaluating them:

  • Expression system: mammalian, microbial, yeast, insect, or plant.
  • Commercial capacity: actual licensed commercial supply vs. only clinical/GMP.
  • Regulatory track record: inspections, approvals, global release experience.
  • Product type fit: glycosylated proteins, enzymes, cytokines, fusion proteins, etc.
  • Geography and supply chain: US/EU/Asia site redundancy, cold chain, import/export.
  • Tech transfer readiness: ability to onboard an existing process quickly.

If you want, I can also give you a shortlist by expression system (e.g., CHO vs. E. coli) or by region (US/EU/Asia).

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (2 observations for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.